Prime Therapeutics' Advocate+ Program Enhances Financial Solutions for Specialty Drugs

Enhancing Access to Specialty Medications

Prime Therapeutics is committed to improving patient access to specialty drugs through the newly launched Advocate+ program. This innovative initiative aims to provide financial solutions and support to members navigating the often challenging process of obtaining these medications, which typically involve higher costs compared to standard retail drugs.

The Challenge of Specialty Drug Procurement

According to Nathan Downhour, Pharm.D., senior vice president at Prime, patients often face daunting challenges when prescribed specialty medications. He emphasizes that the typical expectation—a seamless process from diagnosis to medication retrieval—is frequently disrupted by complex administrative requirements and cost barriers.

Affordability of Specialty Drugs

• The affordability of medications remains a pressing concern, particularly for individuals taking multiple prescriptions.
• A study reveals that 37% of individuals on four or more medications struggle to manage costs.
• Advocate+ will connect patients with essential financial assistance options, including manufacturer coupons and health foundations.

A Data-Driven Solution

Leveraging innovative technology, Advocate+ assesses members’ insurance, clinical, and demographic data to tailor financial assistance. By exploring over 7,000 available programs, Advocate+ successfully matches patients with applicable resources to minimize their out-of-pocket expenses.

Future of Specialty Drug Management

Although Advocate+ comes at a cost for clients, it is positioned to drive savings through efficient specialty drug management, ultimately improving member experiences.